An investigation on behalf of investors in NASDAQ:NVIV)shares over potential wrongdoing at Invivo Therapeutics Holdings was announced and NASDAQ:NVIV stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 04/14/2017 -- An investigation on behalf of investors in shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) was announced over potential breaches of fiduciary duties by certain directors.
Investors who purchased shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Invivo Therapeutics Holdings officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Invivo Therapeutics Holdings Corp reported that its Net Loss declined from 433.31 million in2 105 to $23.44 million in 2016. Shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) declined from $17.78 per share in June 2015 to as low as $3.30 per share on April 13, 2017.
Those who purchased shares of Invivo Therapeutics Holdings Corp have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com